home / stock / impl / impl news

IMPL News and Press, Impel Pharmaceuticals Inc. From 09/08/23

Stock Information
Company Name: Impel Pharmaceuticals Inc.
Stock Symbol: IMPL
Market: NASDAQ
Menu
IMPL IMPL Quote IMPL Short IMPL News IMPL Articles IMPL Message Board
Get IMPL Alerts

News, Short Squeeze, Breakout and More Instantly...
IMPL - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

2023-09-08 07:27:23 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pre-market stock movers are a hot topic worth checking out on Friday with a look at today’s winners and losers! Moving stocks this morning are financial agreements, an earnings repor...
IMPL - Impel Pharma reiterates possible Chapter 11 bankruptcy; down 23%

2023-08-18 11:45:16 ET More on Impel NeuroPharma Impel Pharma Non-GAAP EPS of -$0.97 beats by $0.06, revenue of $5.01M misses by $0.24M Impel cut to Neutral at Wedbush on sales outlook for migraine therapy Impel stock rises as dosing begins in mid-stage trial of INP1...

IMPL - WATT, RETO and MIRO among mid-day movers

2023-08-16 13:38:03 ET Gainers: EBET ( EBET ) +160% . Novo Integrated Sciences ( NVOS ) +71% . Tivic Health Systems ( TIVC ) +58% . WeTrade Group ( WETG ) +43%. DLocal Limited ( DLO ) +35% . JX Luxventure Limited ( JXJT )...

IMPL - Novo Integrated, Aeon top healthcare gainers; Impel, Jupiter Wellness among losers

2023-08-16 10:08:58 ET Gainers: Novo Integrated Sciences ( NVOS ) +86% . Aeon Biopharma ( AEON ) +11% . Biophytis ( BPTS ) +10% . Syros Pharmaceuticals ( SYRS ) +9% . MediciNova ( MNOV ) +8% . Losers: Impel Pharmaceuticals...
IMPL - SCYX, KIND and TSHA among pre-market losers

2023-08-16 08:33:15 ET Sacks Parente Golf ( SPGC ) -38% . Impel Pharmaceuticals ( IMPL ) -36% . SRM Entertainment ( SRM ) -22% announces pricing of its initial public offering . Coherent Corp. ( COHR ) -22% . after Q4 earning release . ...

IMPL - Impel Pharma says Chapter 11 bankruptcy possible; down 30%

2023-08-15 18:04:50 ET More on Impel NeuroPharma Impel NeuroPharma Non-GAAP EPS of -$0.97 beats by $0.06, revenue of $5.01M misses by $0.24M Impel cut to Neutral at Wedbush on sales outlook for migraine therapy For further details see: Impel Pharma says Chapter 1...

IMPL - CCCC and AFRM among pre-market losers

2023-07-06 08:32:06 ET Allarity Therapeutics ALLR -53% after pricing public offering to $11M ASLAN Pharmaceuticals Limited ( ASLN ) -33% to host webcast on July 6, 2023, to discuss phase 2b topline data from TREK-AD trial evaluating Eblasakimab in atopic dermatitis. ...
IMPL - ARVL, MULN and ZUO among mid-day movers

2023-07-05 13:00:26 ET Gainers: Mullen Automotive ( MULN ) +47% . iMedia Brands ( IMBI ) +45% . LightPath Technologies ( LPTH ) +32% . Cibus ( CBUS ) +34% . Impel Pharmaceuticals ( IMPL ) +29% . BioXcel Therapeutics ( BTAI ...

IMPL - Impel, Adicet top healthcare gainers; Amneal, Evelo among losers

2023-07-05 10:02:39 ET Gainers: Impel Pharmaceuticals ( IMPL ) +32% . Adicet Bio ( ACET ) +18% . C4 Therapeutics ( CCCC ) +17% . NLS Pharmaceutics ( NLSP ) +7% . Poseida Therapeutics ( PSTX ) +4% . Losers: Amneal Pharmaceu...

IMPL - Impel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache Society

Real-World Assessment Suggests that Concomitant Preventive and Acute Medication Use Decreases in Patients Using Trudhesa Additional Poster Underscores the Need for Non-Oral Treatment Options Given the Prevalence of Pre-Existing Gastrointestinal Disorders Among Those Prescribed Trudhesa ...
Previous 10 Next 10